Phenotypic Approach to Drug Discovery

Por Pressler, Heather, Figg, W. Douglas
Publicado em 2009

Synthesis of a Stable and Orally Bioavailable Englerin Analogue

Por Fash, David M., Peer, Cody J., Li, Zhenwu, Talisman, Ian J., Hayavi, Sima, Sulzmaier, Florian J., Ramos, Joe W., Sourbier, Carole, Neckers, Leonard, Figg, W. Douglas, Beutler, John A., Chain, William J.
Publicado no Bioorg Med Chem Lett (2016)

A Polymorphic Variant of AFAP-110 Enhances cSrc Activity

Por Clump, David A, Yu, Jing Jie, Cho, YoungJin, Gao, Rui, Jett, John, Zot, Henry, Cunnick, Jess M, Snyder, Brandi, Clump, Anne C, Dodrill, Melissa, Gannett, Peter, Coad, James E, Shurina, Robert, Figg, W Douglas, Reed, Eddie, Flynn, Daniel C
Publicado em 2010

Pharmacodynamic markers and clinical results from the Phase II Study of the SMAC-Mimetic Birinapant in Women with Relapsed Platinum-Resistant or Refractory Epithelial Ovarian Cance...

Por Noonan, Anne M., Bunch, Kristen P., Chen, Jin-Qiu, Herrmann, Michelle A., Lee, Jung-min, Kohn, Elise C., O’Sullivan, Ciara C., Jordan, Elizabeth, Houston, Nicole, Takebe, Naoko, Kinders, Robert J., Cao, Liang, Peer, Cody J., Figg, W. Douglas, Annunziata, Christina M.
Publicado no Cancer (2015)

Phase I Trial of the Combination of Flavopiridol and Imatinib Mesylate in Patients with Bcr-Abl(+) Hematological Malignancies

Por Bose, Prithviraj, Perkins, Edward B, Honeycut, Connie, Wellons, Martha D, Stefan, Tammy, Jacobberger, James W, Kontopodis, Emmanouil, Beumer, Jan H, Egorin, Merrill J, Imamura, Chiyo K, Figg, W Douglas, Karp, Judith E, Koc, Omer N, Cooper, Brenda W, Luger, Selina M, Colevas, A Dimitrios, Roberts, John D, Grant, Steven
Publicado em 2012